Pancreatic Cancer Research

ResearcherKunming Medical UniversityActive in the last 2 years

Renchao Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8598-5528; OpenAlex author ID A5063030529. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 3 papers

Papers 4

  1. METTL3 and METTL14 drive pancreatic adenocarcinoma progression via m6A-dependent alternative splicing in PANC-1 cells. Co-author DOI 10.1007/s12672-025-03393-3↗
  2. O-GlcNAcylation with ubiquitination stabilizes METTL3 to promoting HMGB1 degradation to inhibit ferroptosis and enhance gemcitabine resistance in pancreatic ca… Co-author DOI 10.1186/s10020-025-01285-4↗
  3. miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. Co-author DOI 10.4149/gpb_2024047↗
  4. Downregulation of CDCA3 expression inhibits tumor formation in pancreatic cancer. Co-author DOI 10.4149/neo_2020_200411n388↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bo Tang · 4 shared papers, 2020–2025 · strength 0.87
  2. Dongyun Cun · 2 shared papers, 2025 · strength 0.49
  3. Dong Wei · 2 shared papers, 2025 · strength 0.49
  4. Tao Wu · 2 shared papers, 2025 · strength 0.49
  5. Jiayun Ge · 2 shared papers, 2020–2025 · strength 0.38
  6. Zhihong Zhang · 1 shared paper, 2025 · strength 0.27
  7. Xin Wang · 1 shared paper, 2025 · strength 0.27
  8. Qiuhong Wang · 1 shared paper, 2025 · strength 0.26
  9. Qiuhong Wang · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.